Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Chemotherapy-induced Febrile Neutropenia
Sponsor: Amgen